CA2656032C - Procede de culture de bacteries du genrepiscirickettsia - Google Patents
Procede de culture de bacteries du genrepiscirickettsia Download PDFInfo
- Publication number
- CA2656032C CA2656032C CA2656032A CA2656032A CA2656032C CA 2656032 C CA2656032 C CA 2656032C CA 2656032 A CA2656032 A CA 2656032A CA 2656032 A CA2656032 A CA 2656032A CA 2656032 C CA2656032 C CA 2656032C
- Authority
- CA
- Canada
- Prior art keywords
- bacterium
- vaccine
- bacteria
- culture
- piscirickettsia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 222
- 238000000034 method Methods 0.000 title claims abstract description 107
- 230000008569 process Effects 0.000 title claims abstract description 83
- 238000012258 culturing Methods 0.000 title claims abstract description 25
- 241000192127 Piscirickettsia Species 0.000 title abstract description 66
- 229960005486 vaccine Drugs 0.000 claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000009472 formulation Methods 0.000 claims abstract description 10
- 241000192126 Piscirickettsia salmonis Species 0.000 claims description 66
- 235000019688 fish Nutrition 0.000 claims description 43
- 241000251468 Actinopterygii Species 0.000 claims description 42
- 239000001963 growth medium Substances 0.000 claims description 35
- 108090000623 proteins and genes Proteins 0.000 claims description 26
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 23
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 17
- 230000003287 optical effect Effects 0.000 claims description 16
- 208000037113 Piscirickettsiaceae Infections Diseases 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 150000007523 nucleic acids Chemical group 0.000 claims description 13
- 241000710921 Infectious pancreatic necrosis virus Species 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
- 238000003306 harvesting Methods 0.000 claims description 10
- 230000036541 health Effects 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 238000004113 cell culture Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 208000024891 symptom Diseases 0.000 claims description 9
- 108091023242 Internal transcribed spacer Proteins 0.000 claims description 8
- 230000000644 propagated effect Effects 0.000 claims description 7
- 241001135139 Vibrio ordalii Species 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 241000972773 Aulopiformes Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 235000019515 salmon Nutrition 0.000 claims description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000011026 diafiltration Methods 0.000 claims description 4
- 239000013505 freshwater Substances 0.000 claims description 4
- 241000277263 Salmo Species 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000009295 crossflow filtration Methods 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 239000007927 intramuscular injection Substances 0.000 claims description 3
- 238000010255 intramuscular injection Methods 0.000 claims description 3
- 239000007928 intraperitoneal injection Substances 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 239000011785 micronutrient Substances 0.000 claims description 2
- 235000013369 micronutrients Nutrition 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 230000035764 nutrition Effects 0.000 claims description 2
- 239000007320 rich medium Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 58
- 230000001580 bacterial effect Effects 0.000 description 37
- 239000002609 medium Substances 0.000 description 33
- 239000000725 suspension Substances 0.000 description 27
- 210000001519 tissue Anatomy 0.000 description 15
- 238000010790 dilution Methods 0.000 description 13
- 239000012895 dilution Substances 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 230000000890 antigenic effect Effects 0.000 description 7
- 230000002779 inactivation Effects 0.000 description 7
- 230000003834 intracellular effect Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 241000277331 Salmonidae Species 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000002238 attenuated effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241001494479 Pecora Species 0.000 description 4
- 241000711825 Viral hemorrhagic septicemia virus Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000002540 macrophage Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002864 sequence alignment Methods 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000001042 affinity chromatography Methods 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 231100000676 disease causative agent Toxicity 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108020004418 ribosomal RNA Proteins 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108020005097 23S Ribosomal RNA Proteins 0.000 description 2
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000700723 Ictalurid herpesvirus 1 Species 0.000 description 2
- 241000711804 Infectious hematopoietic necrosis virus Species 0.000 description 2
- 241000546112 Infectious salmon anemia virus Species 0.000 description 2
- 102000011931 Nucleoproteins Human genes 0.000 description 2
- 108010061100 Nucleoproteins Proteins 0.000 description 2
- 241000277338 Oncorhynchus kisutch Species 0.000 description 2
- 238000002944 PCR assay Methods 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000009313 farming Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000013223 septicemia Diseases 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 101150066838 12 gene Proteins 0.000 description 1
- WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241001519451 Abramis brama Species 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000607525 Aeromonas salmonicida Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241001434006 Atractoscion nobilis Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000131482 Bifidobacterium sp. Species 0.000 description 1
- 241000186312 Brevibacterium sp. Species 0.000 description 1
- 101150035271 CHSE gene Proteins 0.000 description 1
- 241001611011 Caligus Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- -1 Cremophore Chemical class 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241001148513 Cytophaga sp. Species 0.000 description 1
- 241000723298 Dicentrarchus labrax Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 241000589564 Flavobacterium sp. Species 0.000 description 1
- 241000589601 Francisella Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 241000276457 Gadidae Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 241000701372 Iridovirus Species 0.000 description 1
- 241001661732 Isavirus Species 0.000 description 1
- 241000178948 Lactococcus sp. Species 0.000 description 1
- 241001247233 Lepeophtheirus Species 0.000 description 1
- 241001627205 Leuconostoc sp. Species 0.000 description 1
- 241001417534 Lutjanidae Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001600139 Moritella viscosa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 201000002481 Myositis Diseases 0.000 description 1
- 241000187681 Nocardia sp. Species 0.000 description 1
- 241000277334 Oncorhynchus Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108700006640 OspA Proteins 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 241000604136 Pediococcus sp. Species 0.000 description 1
- 241001517016 Photobacterium damselae Species 0.000 description 1
- 241000269978 Pleuronectiformes Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000952573 Renibacterium sp. Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 241001385942 Saprolegnia sp. Species 0.000 description 1
- 241000276699 Seriola Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000194022 Streptococcus sp. Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241001454698 Teleostei Species 0.000 description 1
- 108010055044 Tetanus Toxin Proteins 0.000 description 1
- 241000276707 Tilapia Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607284 Vibrio sp. Species 0.000 description 1
- 206010058874 Viraemia Diseases 0.000 description 1
- 108010059722 Viral Fusion Proteins Proteins 0.000 description 1
- 241000131891 Yersinia sp. Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 206010014665 endocarditis Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 208000010824 fish disease Diseases 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 208000010758 granulomatous inflammation Diseases 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002353 niosome Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 238000009372 pisciculture Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 238000001853 pulsed-field electrophoresis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 241001507086 salmonid fish Species 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940118376 tetanus toxin Drugs 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0233—Rickettsiales, e.g. Anaplasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des procédés de culture de bactéries appartenant au genre Piscirickettsia, des procédés de sélection/d'identification de ces bactéries, ainsi que des procédés de fabrication de vaccins. L'invention concerne également des compositions et des préparations vaccinales et des bactéries identifiées et/ou cultivées à l'aide d'un procédé selon l'invention.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200600888 | 2006-06-29 | ||
DKPA200600888 | 2006-06-29 | ||
PCT/NO2007/000239 WO2008002152A2 (fr) | 2006-06-29 | 2007-06-27 | Procédé de culture de bactéries du genre piscirickettsia |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2656032A1 CA2656032A1 (fr) | 2008-01-03 |
CA2656032C true CA2656032C (fr) | 2017-06-13 |
Family
ID=38686744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2656032A Active CA2656032C (fr) | 2006-06-29 | 2007-06-27 | Procede de culture de bacteries du genrepiscirickettsia |
Country Status (4)
Country | Link |
---|---|
CA (1) | CA2656032C (fr) |
CL (1) | CL2007001893A1 (fr) |
GB (1) | GB2452892B (fr) |
WO (1) | WO2008002152A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO333242B1 (no) * | 2008-02-08 | 2013-04-15 | Pharmaq As | Sammensetning, medisinsk anvendelse og fremgangsmate som omfatter salmonid alfavirus |
WO2014198913A2 (fr) * | 2013-06-14 | 2014-12-18 | Cermaq As | Nouvel isolat de piscirickettsia salmonis |
WO2015071769A2 (fr) | 2013-11-13 | 2015-05-21 | University Of Oslo | Vésicules de membrane externe et utilisation associées |
WO2016082050A1 (fr) * | 2014-11-24 | 2016-06-02 | Pontificia Universidad Católica Del Valparaíso | Milieu de culture permettant la croissance de la bactérie piscirickettsia salmonis |
CL2014003575A1 (es) * | 2014-12-30 | 2015-07-10 | Univ Chile | Método basado en pcr-rflp para detectar presencia de piscirickettsia salmonis en una muestra, y establecer si la muestra esta contaminada con otras bacterias que podrían cohabitar con el mencionado patógeno; y kit parallevar a cabo el método. |
WO2024003035A1 (fr) * | 2022-06-27 | 2024-01-04 | Vaxxinova Norway As | Vaccins contre la piscirickettsiose (septicémie rickettsienne des salmonidés) |
-
2007
- 2007-06-27 GB GB0823188A patent/GB2452892B/en active Active
- 2007-06-27 WO PCT/NO2007/000239 patent/WO2008002152A2/fr active Search and Examination
- 2007-06-27 CL CL2007001893A patent/CL2007001893A1/es unknown
- 2007-06-27 CA CA2656032A patent/CA2656032C/fr active Active
Also Published As
Publication number | Publication date |
---|---|
GB0823188D0 (en) | 2009-01-28 |
GB2452892B (en) | 2011-10-12 |
GB2452892A (en) | 2009-03-18 |
WO2008002152A3 (fr) | 2008-03-06 |
CL2007001893A1 (es) | 2008-01-04 |
WO2008002152A8 (fr) | 2009-07-23 |
WO2008002152A2 (fr) | 2008-01-03 |
CA2656032A1 (fr) | 2008-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Romalde | Photobacterium damselae subsp. piscicida: an integrated view of a bacterial fish pathogen | |
AU643829B2 (en) | Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof | |
EP2271663B1 (fr) | Nouvel astrovirus aviaire | |
CN109195623A (zh) | 嵌合型猪圆环病毒2型(pcv2)疫苗 | |
CA2656032C (fr) | Procede de culture de bacteries du genrepiscirickettsia | |
KR20060054352A (ko) | 유럽 기원의 로소니아 인트라셀룰라리스, 및 이의 백신,진단제 및 사용 방법 | |
EP2187958B1 (fr) | Vaccin atténué pour la prévention d'ehrlichiose | |
US6350454B1 (en) | Attenuated Pasteurella piscicida vaccine for fish | |
CN1930185A (zh) | 用于抵抗艾利希体病的犬疫苗 | |
US8404253B2 (en) | Modified live (JMSO strain) Haemophilus parasuis vaccine | |
EP3071226B1 (fr) | Vaccin pour poisson | |
DK180623B1 (en) | Fish virus | |
CN113943714A (zh) | 一种猫杯状病毒毒株及其应用 | |
CN103602637B (zh) | 猪支原体肺炎疫苗株 | |
Yu et al. | C312M: an attenuated Vibrio anguillarum strain that induces immunoprotection as an oral and immersion vaccine | |
US20150252320A1 (en) | Method for continuously culturing ehrlichia canis | |
KR20050039688A (ko) | 조류 질병을 유발하는 신규한 박테리아 및 그로부터유래된 백신 | |
AU2002363173A1 (en) | New bacterium causing poultry disease and vaccine derived thereof | |
ELIASSEN et al. | Sommaire du brevet 2656032 | |
WO2012138836A2 (fr) | Vaccins vivants atténués pour des animaux aquatiques | |
KR101210082B1 (ko) | 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법 | |
ELIASSEN et al. | Patent 2656032 Summary | |
KR101209964B1 (ko) | 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법 | |
CA2915211A1 (fr) | Nouvel isolat de piscirickettsia salmonis | |
CN103585622A (zh) | 猪支原体肺炎疫苗株的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |